![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5925/TOC-Subject-Sample-2021-Bioscience.jpg"})
Abstract
100 uremic patients were studied prior to renal transplantation with regard to serum cytomegalovirus (CMV) antibody using both complement-fixing and virus-neutralizing techniques. CMV antibody was demonstrated in 72, a rate corresponding to what might be expected in non-uremics. Among possible predisposing factors, only blood transfusions appeared to be related to CMV seropositivity.